Description

BSE lists 9,34,887 new equity shares of Kerala Ayurveda Limited on preferential basis, effective April 21, 2026. Shares issued at Rs. 327.99/- each with lock-in periods extending to 2026 and 2027.

Summary

BSE has listed 9,34,887 new equity shares of Kerala Ayurveda Limited (Scrip Code: 530163, ISIN: INE817B01025) issued on a preferential basis to Promoter and Non-Promoter entities. The shares are permitted to trade on the Exchange effective Tuesday, April 21, 2026.

Key Points

  • 9,34,887 equity shares of Rs. 10/- face value issued at a premium of Rs. 317.99/-, totalling an issue price of Rs. 327.99/- per share
  • Shares rank pari-passu with existing equity shares of the company
  • Distribution numbers: 12060199 to 12995085
  • Date of allotment: March 21, 2026
  • Trading permitted from April 21, 2026

Regulatory Changes

No new regulatory changes. This is a standard listing notice pursuant to preferential allotment under existing SEBI and BSE listing regulations.

Compliance Requirements

  • Trading members are informed to update their records for the new scrip details
  • Lock-in restrictions must be observed per the details below; shares under lock-in are not freely tradeable until the respective lock-in expiry dates

Important Dates

  • Date of Allotment: March 21, 2026
  • Trading Commencement: April 21, 2026
  • Lock-in Expiry (6,30,000 shares, Dist. Nos. 12060199–12690198): October 30, 2027
  • Lock-in Expiry (3,04,887 shares, Dist. Nos. 12690199–12995085): October 30, 2026

Impact Assessment

The listing adds approximately 9.35 lakh new shares to the tradeable float of Kerala Ayurveda Limited, though effective free float addition is limited due to lock-in constraints. Only 3,04,887 shares become freely tradeable after October 2026, while the larger tranche of 6,30,000 shares remains locked until October 2027. Market impact is expected to be minimal given the phased unlock schedule and the preferential nature of the allotment.

Impact Justification

Routine listing of preferentially allotted shares for a single company. Lock-in restrictions limit immediate market impact; no broader regulatory or market-wide implications.